BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 25934226)

  • 1. Synthesis and molecular docking of 1,2,3-triazole-based sulfonamides as aromatase inhibitors.
    Pingaew R; Prachayasittikul V; Mandi P; Nantasenamat C; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
    Bioorg Med Chem; 2015 Jul; 23(13):3472-80. PubMed ID: 25934226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and molecular docking studies of novel N-benzenesulfonyl-1,2,3,4-tetrahydroisoquinoline-based triazoles with potential anticancer activity.
    Pingaew R; Mandi P; Nantasenamat C; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
    Eur J Med Chem; 2014 Jun; 81():192-203. PubMed ID: 24836071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, molecular docking, and QSAR study of sulfonamide-based indoles as aromatase inhibitors.
    Pingaew R; Mandi P; Prachayasittikul V; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
    Eur J Med Chem; 2018 Jan; 143():1604-1615. PubMed ID: 29137864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel triazole-tetrahydroisoquinoline hybrids as human aromatase inhibitors.
    Chamduang C; Pingaew R; Prachayasittikul V; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
    Bioorg Chem; 2019 Dec; 93():103327. PubMed ID: 31614285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, molecular docking, and QSAR study of bis-sulfonamide derivatives as potential aromatase inhibitors.
    Leechaisit R; Pingaew R; Prachayasittikul V; Worachartcheewan A; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
    Bioorg Med Chem; 2019 Oct; 27(19):115040. PubMed ID: 31416738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and molecular docking of N,N'-disubstituted thiourea derivatives as novel aromatase inhibitors.
    Pingaew R; Prachayasittikul V; Anuwongcharoen N; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
    Bioorg Chem; 2018 Sep; 79():171-178. PubMed ID: 29758407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and Pharmacophore Study of Triazole Analogues as Aromatase Inhibitors.
    Banjare L
    Anticancer Agents Med Chem; 2024; 24(4):288-303. PubMed ID: 37921212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analogue based drug design, synthesis, molecular docking and anticancer evaluation of novel chromene sulfonamide hybrids as aromatase inhibitors and apoptosis enhancers.
    Ghorab MM; Alsaid MS; Al-Ansary GH; Abdel-Latif GA; Abou El Ella DA
    Eur J Med Chem; 2016 Nov; 124():946-958. PubMed ID: 27770735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual aromatase-steroid sulfatase inhibitors.
    Woo LW; Bubert C; Sutcliffe OB; Smith A; Chander SK; Mahon MF; Purohit A; Reed MJ; Potter BV
    J Med Chem; 2007 Jul; 50(15):3540-60. PubMed ID: 17580845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bicyclic derivatives of the potent dual aromatase-steroid sulfatase inhibitor 2-bromo-4-{[(4-cyanophenyl)(4h-1,2,4-triazol-4-yl)amino]methyl}phenylsulfamate: synthesis, SAR, crystal structure, and in vitro and in vivo activities.
    Wood PM; Woo LW; Labrosse JR; Thomas MP; Mahon MF; Chander SK; Purohit A; Reed MJ; Potter BV
    ChemMedChem; 2010 Sep; 5(9):1577-93. PubMed ID: 20632362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, docking study and cytotoxic activity evaluation of some novel letrozole analogs.
    Vosooghi M; Firoozpour L; Rodaki A; Pordeli M; Safavi M; Ardestani SK; Dadgar A; Asadipour A; Moshafi MH; Foroumadi A
    Daru; 2014 Dec; 22(1):83. PubMed ID: 25539909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and structure-activity relationship of 1- and 2-substituted-1,2,3-triazole letrozole-based analogues as aromatase inhibitors.
    Doiron J; Soultan AH; Richard R; Touré MM; Picot N; Richard R; Cuperlović-Culf M; Robichaud GA; Touaibia M
    Eur J Med Chem; 2011 Sep; 46(9):4010-24. PubMed ID: 21703734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of 4-triazolylflavans as new aromatase inhibitors.
    Yahiaoui S; Pouget C; Fagnere C; Champavier Y; Habrioux G; Chulia AJ
    Bioorg Med Chem Lett; 2004 Oct; 14(20):5215-8. PubMed ID: 15380230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships and docking studies of synthetic 2-arylindole derivatives determined with aromatase and quinone reductase 1.
    Prior AM; Yu X; Park EJ; Kondratyuk TP; Lin Y; Pezzuto JM; Sun D
    Bioorg Med Chem Lett; 2017 Dec; 27(24):5393-5399. PubMed ID: 29153737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, biological evaluation, and docking study of indole aryl sulfonamides as aromatase inhibitors.
    Fantacuzzi M; De Filippis B; Gallorini M; Ammazzalorso A; Giampietro L; Maccallini C; Aturki Z; Donati E; Ibrahim RS; Shawky E; Cataldi A; Amoroso R
    Eur J Med Chem; 2020 Jan; 185():111815. PubMed ID: 31732252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel 1,2,3-Triazole Derivatives as Mimics of Steroidal System-Synthesis, Crystal Structures Determination, Hirshfeld Surfaces Analysis and Molecular Docking.
    Daśko M; Dołęga A; Siedzielnik M; Biernacki K; Ciupak O; Rachon J; Demkowicz S
    Molecules; 2021 Jul; 26(13):. PubMed ID: 34279404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, investigation of biological effects and in silico studies of new benzimidazole derivatives as aromatase inhibitors.
    Sağlık BN; Şen AM; Evren AE; Çevik UA; Osmaniye D; Kaya Çavuşoğlu B; Levent S; Karaduman AB; Özkay Y; Kaplancıklı ZA
    Z Naturforsch C J Biosci; 2020 Sep; 75(9-10):353-362. PubMed ID: 32681791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of 1,2,4-triazoles as new thymidine phosphorylase inhibitors: Future anti-tumor drugs.
    Shahzad SA; Yar M; Khan ZA; Shahzadi L; Naqvi SAR; Mahmood A; Ullah S; Shaikh AJ; Sherazi TA; Bale AT; Kukułowicz J; Bajda M
    Bioorg Chem; 2019 Apr; 85():209-220. PubMed ID: 30634096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of a novel class of aldol-derived 1,2,3-triazoles: potent and selective inhibitors of human cytochrome P450 19A1 (aromatase).
    McNulty J; Nair JJ; Vurgun N; Difrancesco BR; Brown CE; Tsoi B; Crankshaw DJ; Holloway AC
    Bioorg Med Chem Lett; 2012 Jan; 22(1):718-22. PubMed ID: 22079757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DESIGN, SYNTHESIS AND ANTICANCER ACTIVITY OF SOME NOVEL 1,2,4-TRIAZOLES CARRYING BIOLOGICALLY ACTIVE SULFONAMIDE MOIETIES.
    Ghorab MM; Alsaid MS; Al-Dosari M
    Acta Pol Pharm; 2016 Sep; 73(5):1147-1153. PubMed ID: 29638055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.